Non-Financial Information Statement

Overview

The report describes Insud Pharma's 2023 dual materiality assessment and extensive environmental management across its manufacturing plants. It reports total energy consumption of 180,248.9 MWh and a year-end workforce of 7,041 employees, alongside Scope 1 and Scope 2 emissions data. The company also details occupational safety, training, equality, human-rights, anti-corruption, supplier, and community-health initiatives, including work through the Mundo Sano Foundation.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2023
Period: 1 January 2023 – 31 December 2023
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services